GDF-15 Levels in Risk Stratification in Acute Pulmonary Embolism

NCT03672123 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 270

Last updated 2023-10-31

No results posted yet for this study

Summary

Prospective observational study evaluating serum GDF-15 levels in patients with acute pulmonary embolism.

Conditions

Sponsors & Collaborators

  • National Science Center, Poland

    collaborator UNKNOWN
  • Medical University of Warsaw

    lead OTHER

Principal Investigators

  • Marta Z Skowronska, MD · Medical University of Warsaw

  • Piotr Pruszczyk, Prof. · Medical University of Warsaw

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-17
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • Poland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03672123 on ClinicalTrials.gov